Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Recruiting 3Completed 3Withdrawn 1Unknown 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Depression 3Anxiety Disorders 3Neoplasms 2Ovarian Neoplasms 1Opioid-Related Disorders 1Neoplasm Metastasis 1Depressive Disorder 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Agnosia 1

Interventions

Therapeutics 4Psilocybin 3Surveys and Questionnaires 2Oxygen 2Methods 2Cognitive Behavioral Therapy 2enzalutamide 1darolutamide 1apalutamide 1abacavir 1Transurethral Resection of Prostate 1Transcranial Magnetic Stimulation 1Transcranial Direct Current Stimulation 1Thyroidectomy 1Standard of Care 1Saline Solution 1Psychotherapy 1Physical Examination 1Palliative Care 1Niacin 1Models, Nursing 1Mindfulness 1Methylphenidate 1Melatonin 1Injections 1Infliximab 1Hypnosis 1Ethanol 1Esketamine 1Early Detection of Cancer 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Depression × Psilocybin × Clear all
NCT07336238 2026-05-29

Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies

University of Washington

Phase 2 Recruiting
18 enrolled

Anxiety Disorders, Depression, Neoplasm Metastasis

NCT06200155 2026-04-16

Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy

M.D. Anderson Cancer Center

Phase 2 Recruiting
30 enrolled

Anxiety Disorders, Depression

NCT06801041 2026-04-16

TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors

M.D. Anderson Cancer Center

Phase 2 Recruiting
20 enrolled

Anxiety Disorders, Depression, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡